-
1
-
-
0034461768
-
Drug-like properties and the causes of poor solubility and poor permeability
-
Lipinski, C. A. Drug-like properties and the causes of poor solubility and poor permeability J. Pharmacol. Toxicol. Methods 2000, 44, 235-249
-
(2000)
J. Pharmacol. Toxicol. Methods
, vol.44
, pp. 235-249
-
-
Lipinski, C.A.1
-
4
-
-
39149095938
-
Advanced screening assays to rapidly identify solubility-enhancing formulations: High-throughput, miniaturization and automation
-
Dai, W.-G.; Pollock-Dove, C.; Dong, L. C.; Li, S. Advanced screening assays to rapidly identify solubility-enhancing formulations: High-throughput, miniaturization and automation Adv. Drug Delivery Rev. 2008, 60, 657-672
-
(2008)
Adv. Drug Delivery Rev.
, vol.60
, pp. 657-672
-
-
Dai, W.-G.1
Pollock-Dove, C.2
Dong, L.C.3
Li, S.4
-
5
-
-
53949092998
-
Top-down production of drug nanocrystals: Nanosuspension stabilization, miniaturization and transformation into solid products
-
Van Eerdenbrugh, B.; Van den Mooter, P.; Augustijns, P. Top-down production of drug nanocrystals: Nanosuspension stabilization, miniaturization and transformation into solid products Int. J. Pharm. 2008, 364, 64-75
-
(2008)
Int. J. Pharm.
, vol.364
, pp. 64-75
-
-
Van Eerdenbrugh, B.1
Van Den Mooter, P.2
Augustijns, P.3
-
6
-
-
84857963606
-
-
BASF, web based publication, 9 Sept.
-
BASF, Pharma Solutions, web based publication, 9 Sept 2008.
-
(2008)
Pharma Solutions
-
-
-
7
-
-
0141830659
-
Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics
-
Allémann, E.; Leroux, J.-C.; Gurny, R. Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics Adv. Drug Delivery Rev. 1998, 34, 171-189
-
(1998)
Adv. Drug Delivery Rev.
, vol.34
, pp. 171-189
-
-
Allémann, E.1
Leroux, J.-C.2
Gurny, R.3
-
8
-
-
0034690936
-
Combined effect of oleic acid and polyethylene glycol 200 on buccal permeation of [D-ala2, D-leu5]enkephalin from a cubic phase of glyceryl monooleate
-
Lee, J; Kellaway, I. W. Combined effect of oleic acid and polyethylene glycol 200 on buccal permeation of [D-ala2, D-leu5]enkephalin from a cubic phase of glyceryl monooleate Int. J. Pharm. 2000, 204, 137-144
-
(2000)
Int. J. Pharm.
, vol.204
, pp. 137-144
-
-
Lee, J.1
Kellaway, I.W.2
-
9
-
-
0025233547
-
Solute absorption from the airways of the isolated rat lung. II. Effect of surfactants on absorption of fluorescein
-
Niven, R. W.; Byron, P. R. Solute absorption from the airways of the isolated rat lung. II. Effect of surfactants on absorption of fluorescein Pharm. Res. 1990, 7, 8-13
-
(1990)
Pharm. Res.
, vol.7
, pp. 8-13
-
-
Niven, R.W.1
Byron, P.R.2
-
10
-
-
43249107914
-
Development of nonsurfactant cyclodextrin nanoparticles loaded with anticancer drug paclitaxel
-
Bilensoy, E.; Gu, O.; Rkaynak, M.; Ertan, M. S.; En, A. A.; Hincal Development of nonsurfactant cyclodextrin nanoparticles loaded with anticancer drug paclitaxel J. Pharm. Sci. 2008, 97, 1519-1529
-
(2008)
J. Pharm. Sci.
, vol.97
, pp. 1519-1529
-
-
Bilensoy, E.1
Gu, O.2
Rkaynak, M.3
Ertan, M.S.4
En, A.A.5
Hincal6
-
12
-
-
84857962687
-
-
accessed online October
-
Eastman, Application and Properties, http://www.parmentier.de/gpf/ tpgsbrosch.pdf, (accessed online October 2005).
-
(2005)
Eastman, Application and Properties
-
-
-
13
-
-
66249101601
-
Solubility advantage of pharmaceutical co-crystals
-
Good, D. J.; Rodriguez-Hornedo, N. Solubility advantage of pharmaceutical co-crystals Cryst. Growth Des. 2009, 9, 2252-2264
-
(2009)
Cryst. Growth Des.
, vol.9
, pp. 2252-2264
-
-
Good, D.J.1
Rodriguez-Hornedo, N.2
-
14
-
-
84857926292
-
-
Patent No. WO 2006/007448 A2.
-
McMahon, J.; Peterson, M.; Zaworotko, M. J.; Shattock, T.; Bourghol Hickey, M. Pharmaceutical co-crystals compositions and related methods of use. Patent No. WO 2006/007448 A2, 2005.
-
(2005)
Pharmaceutical Co-crystals Compositions and Related Methods of Use
-
-
McMahon, J.1
Peterson, M.2
Zaworotko, M.J.3
Shattock, T.4
Bourghol Hickey, M.5
-
15
-
-
65249109747
-
Discovering new co-crystals
-
ter Horst, J. H.; Deij, M. A.; Cains, P. W. Discovering new co-crystals Cryst. Growth Des. 2009, 9 (3) 1531-1537
-
(2009)
Cryst. Growth Des.
, vol.9
, Issue.3
, pp. 1531-1537
-
-
Ter Horst, J.H.1
Deij, M.A.2
Cains, P.W.3
-
16
-
-
34548212019
-
Comparison of the effect of tromethamine and polyvinylpyrrolidone on dissolution properties and analgesic effect of nimesulide
-
Abdelkader, H.; Abdallah, O. Y.; Salem, H. S. Comparison of the effect of tromethamine and polyvinylpyrrolidone on dissolution properties and analgesic effect of nimesulide AAPS PharmSciTech 2007, 8, 3
-
(2007)
AAPS PharmSciTech
, vol.8
, pp. 3
-
-
Abdelkader, H.1
Abdallah, O.Y.2
Salem, H.S.3
-
17
-
-
66849143392
-
Salt or co-crystals? A new series of crystal structures formed from simple pyridines and carboxylic acids
-
Mohamed, S.; Tocher, D. A.; Vickers, M.; Karamertzanis, P. G.; Price, S. L. Salt or co-crystals? A new series of crystal structures formed from simple pyridines and carboxylic acids Cryst. Growth Des. 2009, 9 (6) 2881-2889
-
(2009)
Cryst. Growth Des.
, vol.9
, Issue.6
, pp. 2881-2889
-
-
Mohamed, S.1
Tocher, D.A.2
Vickers, M.3
Karamertzanis, P.G.4
Price, S.L.5
-
18
-
-
84873656102
-
-
Venczel, M.; Ujhelyi, G.; Sovány, T.; Pintye-Hódi, K. Flow through dissolution-a useful tool from discovery phase to preclinical development, submitted.
-
Flow Through Dissolution - A Useful Tool from Discovery Phase to Preclinical Development, Submitted.
-
-
Venczel, M.1
Ujhelyi, G.2
Sovány, T.3
Pintye-Hódi, K.4
-
19
-
-
34250814473
-
Celecoxib:nicotinamide dissociation: Using excipients to capture the cocrystal's potential
-
Remenar, J. F.; Peterson, M. L.; Stephens, P. W.; Zhang, Z.; Zimenkov, Y.; Hickey, M. B. Celecoxib:nicotinamide dissociation: using excipients to capture the cocrystal's potential Mol. Pharmaceutics 2007, 4 (3) 386-400
-
(2007)
Mol. Pharmaceutics
, vol.4
, Issue.3
, pp. 386-400
-
-
Remenar, J.F.1
Peterson, M.L.2
Stephens, P.W.3
Zhang, Z.4
Zimenkov, Y.5
Hickey, M.B.6
-
20
-
-
33846930871
-
Biomedical nanotechnology for molecular imaging, profiling, and drug targeting
-
Kim, G.; O'regan, R.; Nie, S. Biomedical nanotechnology for molecular imaging, profiling, and drug targeting Conf. Proc. IEEE Eng. Med. Biol. Soc. 2005, 1, 714-716
-
(2005)
Conf. Proc. IEEE Eng. Med. Biol. Soc.
, vol.1
, pp. 714-716
-
-
Kim, G.1
O'Regan, R.2
Nie, S.3
-
21
-
-
0029661705
-
Effects of cyclosporin and cremophor on working rat heart and incidence of myocardial lipid peroxidation
-
Tatou, E.; Mossiat, C.; Maupoil, V.; Gabrielle, F.; David, M.; Rochette, L. Effects of cyclosporin and cremophor on working rat heart and incidence of myocardial lipid peroxidation Pharmacology 1996, 52, 1-7
-
(1996)
Pharmacology
, vol.52
, pp. 1-7
-
-
Tatou, E.1
Mossiat, C.2
Maupoil, V.3
Gabrielle, F.4
David, M.5
Rochette, L.6
-
22
-
-
0142247609
-
Onycholysis secondary to multiple paclitaxel 1-h infusions: Possible role for its vehicle (Cremophor EL)
-
De Giorgi, U.; Rosti, G.; Monti, M.; Frassineti, G. L.; Marangolo, M. Onycholysis secondary to multiple paclitaxel 1-h infusions: possible role for its vehicle (Cremophor EL) Ann. Oncol. 2003, 14, 1588-1589
-
(2003)
Ann. Oncol.
, vol.14
, pp. 1588-1589
-
-
De Giorgi, U.1
Rosti, G.2
Monti, M.3
Frassineti, G.L.4
Marangolo, M.5
|